| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (31593) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
215 |
| Staphylococcus aureus (31593) |
- |
- |
0.5 － ? |
Clindamycin (Cleocin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
0.5 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
1 － ? |
Amikacin (Amikin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
1 － ? |
Ampicillin (Omnipen) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
1 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
2 － ? |
Cefotaxime (Cephotaxime, Claforan) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
2 － ? |
Cefoxitin (Mefoxin) |
215 |
| Staphylococcus aureus (31593) |
- |
- |
8 － ? |
Lincomycin (Lincocin) |
184 |
| Staphylococcus aureus (31593) |
- |
- |
8 － ? |
Streptomycin |
215 |
| Staphylococcus aureus (31593) |
- |
- |
8 － ? |
Vernamycin B |
215 |
| Staphylococcus aureus (31593) |
- |
- |
32 － ? |
Chloramphenicol (Chloromycetin) |
215 |
| Staphylococcus aureus (319/08 + methicillin-susceptible) |
- |
- |
2 － ? |
Monensin A |
1025 |
| Staphylococcus aureus (319/08 + methicillin-susceptible) |
- |
- |
6.25 － ? |
N-phenylamide of monensin A (M-AM1) |
1025 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
0.25 － ? |
Daptomycin (Cubicin) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
0.5 － ? |
Quinupristin/Dalfopristin (Synercid) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
2 － ? |
Gatifloxacin (Tequin) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
2 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
5 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1034 |
| Staphylococcus aureus (32 + methicillin-resistant) |
- |
- |
16 － ? |
Levofloxacin (Levaquin, Quixin) |
1034 |
| Staphylococcus aureus (320/08 + methicillin-susceptible) |
- |
- |
2 － ? |
Monensin A |
1025 |
| Staphylococcus aureus (320/08 + methicillin-susceptible) |
- |
- |
12.5 － ? |
N-phenylamide of monensin A (M-AM1) |
1025 |
| Staphylococcus aureus (321/08 + methicillin-susceptible) |
- |
- |
2 － ? |
Monensin A |
1025 |
| Staphylococcus aureus (321/08 + methicillin-susceptible) |
- |
- |
12.5 － ? |
N-phenylamide of monensin A (M-AM1) |
1025 |
| Staphylococcus aureus (322/08 + methicillin-susceptible) |
- |
- |
2 － ? |
Monensin A |
1025 |
| Staphylococcus aureus (322/08 + methicillin-susceptible) |
- |
- |
12.5 － ? |
N-phenylamide of monensin A (M-AM1) |
1025 |